Organization score is the sum of its models
Massachusetts Institute of Technology
Benefit
+0.95
Harm
0.00
Net Good
0.95
Timeline
Models
| Rank | Model | Organization | Benefit | Harm | Net | Events | Last impact |
|---|---|---|---|---|---|---|---|
| 1 | Boltz-1 | Massachusetts Institute of Technology | +0.52 | 0.00 | 0.52 | 1 | 19 Nov 2024 |
| 2 | Chemprop Ensemble Internal Research Model Chemprop · internal / unreleased | Massachusetts Institute of Technology | +0.35 | 0.00 | 0.35 | 1 | 20 Dec 2023 |
| 3 | Chemprop-style Internal Research Model Chemprop · internal / unreleased | Massachusetts Institute of Technology | +0.08 | 0.00 | 0.08 | 1 | 25 May 2023 |
Domains
Biology0.52
Medicine & Health0.43
Events
Benefit19 Nov 2024
Boltz-1 releases an MIT-licensed AlphaFold 3–level complex predictor
MIT Jameel Clinic researchers released Boltz-1 in November 2024 as a fully open biomolecular complex model with training code, claiming AF3-level accuracy and an inference-time steering method.
BiologyverifiedTier 2 Notable+0.52
Benefit20 Dec 2023
Explainable graph networks identify a new MRSA-active antibiotic class
MIT and Broad researchers used ensembles of graph neural networks over 12 million compounds to find a structural class active against MRSA and VRE in mice, published 20 December 2023 in Nature.
Medicine & HealthverifiedTier 3 Major+0.35
Benefit25 May 2023
Deep learning identifies abaucin, a narrow-spectrum Acinetobacter antibiotic
MIT and McMaster researchers trained a neural net on in-vitro growth data and identified abaucin, which killed A. baumannii in culture and a mouse wound model, published 25 May 2023.
Medicine & HealthverifiedTier 2 Notable+0.08
All events